Article
The potential of signal peptide peptidase as a therapeutic target for hepatitis C.
Expert opinion on therapeutic targets - 1 Sept 2017
Moriishi Kohji
Abstract excerpt
INTRODUCTION: Chronic infection with hepatitis C virus (HCV) causes liver steatosis, cirrhosis, metabolic syndrome with inflammation, and eventually leads to hepatocellular carcinoma. HCV core protein is a well-known capsid protein and pathogenic factor related to lipid accumulation, type 2 diabetes mellitus, and carcinogenesis. Cleavage of the C-terminal transmembrane region by signal peptide peptidase (SPP) is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
